Cardio-Oncology Working Group

The mission of the Cardio-Oncology Working Group is to create a unique multidisciplinary group to foster a collaborative environment between researchers and clinicians who are interested in the field of cardio-oncology (cardiotoxicity of anticancer therapies) to improve the outcomes of cancer patients. The objectives of this working group are to advance cardio-oncology through basic and translational research and to foster early-career investigators.

Current areas of interest include:

  • Anthracycline-induced cardiomyopathy
  • Proteasome inhibitor-related cardiotoxicity
  • Radiation therapy-related cardiotoxicity
  • Immune checkpoint inhibitor-related cardiotoxicities
  • Exercise intervention in cancer patients
  • Disparities in cardiotoxicity in cancer patients
  • Cardioprotective agents
  • Genetics of cardio-oncology

Meeting agenda items will vary and can include:

  • Presenting results of studies
  • Presentation and discussion of recent publications in the field
  • Identification of collaborators
  • Discussion to create additional collaborative grant applications
  • Presentation of early-stage ideas for feedback
  • Discussion to help strengthen proposals before submission to funding agencies
  • Presentation by an outside expert

Chairs

Katelyn A Bruno
Department: MD-CARDIOLOGY

Katelyn A Bruno PhD, FHFSA

Assistant Professor Of Cardiovascular Medicine
Phone: (352) 273-9064
Yan Gong
Department: Pharmacotherapy & Translational Research

Yan Gong Ph.D.

Associate Professor
Phone: (352) 273-6297

Working Group Committee

Demetra Christou, Ph.D., FAHA
Associate Professor, Department of Applied Physiology & Kinesiology, UF College of Health and Human Performance
Phone: 352-294-1715
Email: ddchristou@ufl.edu

Lakeshia Cousin, Ph.D., APRN, AGPCNP-BC
Assistant Professor, Department of Family, Community and Health Systems Science, UF College of Nursing
Phone: 352-273-6318
Email: lakeshiacousin@ufl.edu

Walter O’Dell, Ph.D.
Associate Professor, Department of Radiation Oncology, UF College of Biomedical Engineering and Medical Physics
Phone: 352-265-7834
Email: ODELWG@shands.ufl.edu

Ashley Smuder, Ph.D.
Assistant Professor, Department of Applied Physiology & Kinesiology, UF College of Health & Human Performance
Phone: 352-294-1765
Email: asmuder@ufl.edu

Jennifer Woodard, M.P.H., CCRP
Director, Office of Community Outreach & Engagement, UF Health Cancer Center
Associate Director, Clinical Research, Department of Health Outcomes and Biomedical Informatics
Phone: 352-294-5974
Email: jenwoodard@ufl.edu

For more information about the group, please contact Katelyn Bruno, Ph.D., FHFSA, at Katelyn.Bruno@medicine.ufl.edu or Yan Gong, Ph.D., at gong@cop.ufl.edu.

Cardio-Oncology Related Funding Opportunities

Title (Tablepress)OrganizationLOI DateStart Time (Calender)Keywords
MRF Breakthrough Consortium (MRFBC) Pilot Translational Award Funded by the Brodman Charitable Fund & FriendsMelanoma Research Foundation (MRF)2/20/2024melanoma, translational research, pilot studies, collaboration, innovative approaches
Translational Adult Glioma Grant AwardIvy Foundation3/1/2024adult glioma, translational research, clinical trials, biomarkers, targeted therapies
Established Investigator Awards (EIA)Melanoma Research Foundation (MRF)3/1/2024melanoma, established investigators, clinical research, translational research, innovative therapies
Research GrantsCURE Childhood Cancer Inc2/15/20243/25/2024Childhood cancer, all types, translational research, clinical trials
2024 Clinical Research Award (CRA)Children's Tumor Foundation2/12/20244/1/2024Pediatric cancer, clinical research, translational research, targeted therapies
Institutional Research GrantsAmerican Cancer Society (ACS)4/1/2024Established cancer research institutions, collaborative research
Catapult Award ProgramCureSearch for Children's Cancer1/16/20244/15/2024pediatric cancer, innovation, translational research, clinical trials, personalized medicine
New Investigator Research Grant ProgramLeukemia Research Foundation, Inc.2/16/20244/26/2024Leukemia, Lymphoma, Translational Research, early-stage
Rising Tide/LUNGevity Team Award Program to Target Mechanisms of Resistance AwardLUNGevity Foundation2/9/20245/8/2024Lung cancer resistance mechanisms, collaborative research
Career Development Awards for Translational ResearchLUNGevity Foundation2/9/20245/8/2024Translational lung cancer research, early-stage investigators
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed?National Institutes of Health5/5/20246/5/2024global health, career development, collaborative research
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)National Institutes of Health6/5/2024Animal models, Translational research,
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)National Institutes of Health6/5/2024Translational Research, Mammalian Models, Clinical Trial Not Allowed
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)National Institutes of Health5/16/20246/16/2024rained immunity, immune mechanisms, translational research, non-clinical
Damon Runyon Cancer Research FoundationDamon Runyon Cancer Research Foundation7/8/2024cancer research, innovation, clinical trials, young investigators, translational research
2024 Translational Research Award?METAvivor3/11/20248/22/2024Breast cancer, translational research, bench-to-bedside, clinical implications
Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)National Cancer Institute11/4/202312/4/2024Kaposi sarcoma herpesvirus, virus, vaccine, therapeutic, innovation
NCI Cancer Center badge